HIV-1 interactions with sialic acid-binding bacterial lectins promote virus infectivity in vitro and mucosal transmission in humanized mice

This study demonstrates that sialic acid-binding lectins from common human microbiota bacteria, particularly SLBR-N from *Streptococcus gordonii*, enhance HIV-1 infectivity and mucosal transmission both in vitro and in humanized mice, revealing a direct role for the microbiome in modulating HIV acquisition risk.

The Gist

Imagine your body's mucosal surfaces (like the lining of the mouth, gut, or rectum) as a busy, crowded marketplace. This marketplace is usually filled with friendly local residents: the bacteria that make up your natural microbiome. For a long time, scientists thought HIV-1 (the virus that causes AIDS) only cared about how it interacted with human cells, ignoring the bacterial "neighbors" living right next door.

This paper asks a simple question: What happens when HIV-1 meets these bacterial neighbors?

The "Velcro" Effect

The researchers discovered that certain bacteria in our bodies produce special proteins called lectins. Think of these lectins as tiny, super-sticky "Velcro" strips.

• The Virus: HIV-1 is covered in a fuzzy coat made of sugar molecules (sialoglycans).
• The Bacteria: Some common bacteria, like Streptococcus gordonii and Staphylococcus aureus, carry these "Velcro" lectins.
• The Interaction: When the virus and the bacteria meet, the bacterial "Velcro" grabs onto the virus's fuzzy sugar coat.

The Results: A Faster, Stronger Attack

The study found that when these bacterial "Velcro" strips grab the virus, they don't just hold it; they actually supercharge it.

1. Better Grip: The bacteria act like a bridge or a launchpad. They grab the virus and stick it firmly to human cells, making it much easier for the virus to get inside and start an infection.
2. The Champion: Among all the bacterial "Velcro" strips tested, one specific type from Streptococcus gordonii (called SLBR-N) was the strongest. It grabbed the virus the best and helped it infect cells the fastest.
3. It Works Everywhere: This boosting effect happened whether the virus was trying to infect cells directly in a test tube or trying to cross barriers in the body (mucosal surfaces). It worked even when other human proteins tried to help or hinder the process.

The Real-World Test: Humanized Mice

To see if this mattered in a living body, the scientists used "humanized mice" (mice with human immune systems).

• They gave the mice a dose of the strongest bacterial "Velcro" (SLBR-N) before exposing them to HIV.
• The Outcome: The mice that had the bacterial "Velcro" got infected much more easily. They had higher amounts of virus in their blood and spleen compared to mice that didn't have the bacterial boost.

The Big Picture

The main takeaway is that the bacteria living in our bodies aren't just passive bystanders. Some of them carry tools that can accidentally help HIV-1 get a better grip on our cells, making it easier for the virus to cross mucosal barriers and establish an infection.

In short: The "neighborhood bacteria" can sometimes act as a molecular booster seat, helping HIV-1 climb into human cells more easily than it could on its own.

Technical Summary

Technical Summary

Problem Statement
The majority of HIV-1 transmission events occur at mucosal surfaces, environments heavily colonized by the host microbiota. Despite the ubiquity of bacteria in these niches, the specific interactions between HIV-1 and bacterial components, particularly those derived from the human microbiome, remain poorly characterized. Consequently, the biological consequences of these interactions on viral infectivity and transmission risk are largely unexplored. This study addresses the gap in understanding how sialic acid-binding lectins expressed by common bacterial species might influence HIV-1 pathogenesis.

Methodology
The researchers evaluated the effects of sialic acid-binding lectins on HIV-1 infectivity using a multi-faceted approach:

• In Vitro Models: Viruses were produced in 293T cells and human primary cells. The study tested the impact of specific lectins from Streptococcus gordonii (Siglec-like binding region lectins: SLBR-N, SLBR-H, and SLBR-B) and Staphylococcus aureus (Staphylococcal superantigen-like lectins: SSL3, SSL4, and SSL11).
• Infection Assays: Infectivity was measured through direct infection of TZM-bl reporter cells and primary CD4+ T cells. The study also examined trans-infection mechanisms, both in the presence and absence of the host lectin DC-SIGN.
• Binding Analysis: The ability of lectins to bind virions and promote virus-cell attachment was assessed to determine the mechanism of enhancement.
• In Vivo Models: Findings were corroborated using humanized mice. These models were pre-exposed to SLBR-N prior to rectal HIV-1 challenge to assess transmission rates and viral burdens in plasma and splenic cells.

Key Contributions and Results
The study demonstrates that sialic acid-binding bacterial lectins enhance HIV-1 infectivity in a sialoglycan-dependent manner.

• Differential Potency: Among the tested lectins, SLBR-N from S. gordonii exhibited the greatest potency. This correlated with its superior ability to bind virions and facilitate virus-cell attachment.
• Mechanism of Action: The enhancing activity was observed across different infection models, including direct infection and trans-infection, regardless of DC-SIGN presence.
• In Vivo Confirmation: In humanized mice, pre-exposure to SLBR-N significantly promoted rectal HIV-1 transmission. This pre-exposure also led to increased viral burdens in both plasma and splenic cells compared to controls.

Significance
The paper concludes that sialoglycan-binding bacterial lectins function as microbial factors capable of enhancing HIV-1 transmission at mucosal surfaces. By demonstrating that specific components of the microbiota can directly modulate viral acquisition risk, the study highlights a potential direct role for the microbiome in HIV-1 pathogenesis. These findings suggest that bacterial products, previously uncharacterized in this context, may be critical determinants in the efficiency of mucosal HIV-1 transmission.